Solynacin generally refers to Solynacin Succinate Tablets. Generally, Solynasin Succinate Tablets begin to work after 2 weeks of use. Current research suggests that Solifenacin Succinate Tablets begin to work after 2 weeks of use, with maximum effect occurring as early as about 4 weeks of use and lasting for at least 12 months. After 12 weeks of treatment with Solifenacin Succinate, 50% of patients with urinary incontinence were cured, and another 35% achieved the goal of urinating less than 8 times per day. Solifenacin Succinate Tablets are indicated for the treatment of urinary incontinence, urinary frequency, and urgency in patients with overactive bladder disease. Common adverse reactions include urinary retention, dysuria, and dry mouth. Solifenacin succinate tablets should be contraindicated in patients with urinary retention, severe gastrointestinal disorders (including toxic megacolon), myasthenia gravis, or narrow-angle glaucoma. If any of the above adverse reactions or other physical discomfort occurs while taking Solynasin Succinate Tablets, seek medical attention.